Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

Author to whom correspondence should be addressed.

Int. J. Mol. Sci. 2020, 21(7), 2269; https://doi.org/10.3390/ijms21072269

Received: 8 January 2020 / Revised: 15 March 2020 / Accepted: 19 March 2020 / Published: 25 March 2020

(This article belongs to the Special Issue The Alveolar Epithelium: Mechanisms of Injury and Repair)

View Full-Text Download PDF

Browse Figures

Review Reports Citation Export

Abstract

: Alveolar epithelial type II cells (AT2) are a heterogeneous population that have critical secretory and regenerative roles in the alveolus to maintain lung homeostasis. However, impairment to their normal functional capacity and development of a pro-fibrotic phenotype has been demonstrated to contribute to the development of idiopathic pulmonary fibrosis (IPF). A number of factors contribute to AT2 death and dysfunction. As a mucosal surface, AT2 cells are exposed to environmental stresses that can have lasting effects that contribute to fibrogenesis. Genetical risks have also been identified that can cause AT2 impairment and the development of lung fibrosis. Furthermore, aging is a final factor that adds to the pathogenic changes in AT2 cells. Here, we will discuss the homeostatic role of AT2 cells and the studies that have recently defined the heterogeneity of this population of cells. Furthermore, we will review the mechanisms of AT2 death and dysfunction in the context of lung fibrosis. View Full-Text

Keywords: alveolar epithelial cells; pulmonary fibrosis; epithelial cell dysfunction; stem cell exhaustion

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share and Cite

MDPI and ACS Style

Parimon, T.; Yao, C.; Stripp, B.R.; Noble, P.W.; Chen, P. Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis. Int. J. Mol. Sci. 2020, 21, 2269. https://doi.org/10.3390/ijms21072269

AMA Style

Parimon T, Yao C, Stripp BR, Noble PW, Chen P. Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences. 2020; 21(7):2269. https://doi.org/10.3390/ijms21072269

Chicago/Turabian Style

Parimon, Tanyalak, Changfu Yao, Barry R Stripp, Paul W Noble, and Peter Chen. 2020. "Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis" International Journal of Molecular Sciences 21, no. 7: 2269. https://doi.org/10.3390/ijms21072269

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

Printed Edition

Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI